Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Clinical trial NCT04524702 · COMPLETED

Trial details

NCT number: NCT04524702
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2020-09-14
Primary completion: 2023-06-06
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.